Event time: 事件时间:
Published: 文章发布:
Key Results
Actual vs Consensus
EPS: $1.23 vs $1.20 estimate, beat+2.5%.Revenue: $764M vs $792M estimate, missed-3.6%.Profitability and Cash Flow
Period: 2026 Q3 period ended 2026-09-30Revenue: $764M; YoY: -0.7%; QoQ: -3.3%Operating income: $178M; Operating margin: 23.2%; YoY: +31.5%; QoQ: -2.7%Net income: $141M; GAAP diluted EPS: $1.04; YoY: +18.7%; QoQ: -6.9%Operating cash flow: $265M; Capex: $40M; Free cash flow: $225MCash: $441M; Total debt: $108M; Net cash: $334MOfficial release: Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
核心结果
实际值与市场预期
EPS:$1.23 vs $1.20 预期,高于预期+2.5%。营收:$764M vs $792M 预期,低于预期-3.6%。财务指标
期间:2026 Q3(截至 2026-09-30)营收:$764M;同比:-0.7%;环比:-3.3%经营利润:$178M;经营利润率:23.2%;同比:+31.5%;环比:-2.7%净利润:$141M;GAAP 稀释 EPS:$1.04;同比:+18.7%;环比:-6.9%经营现金流:$265M;资本开支:$40M;自由现金流:$225M现金:$441M;总债务:$108M;净现金:$334M